Wessex Medical Financial Services Limited 12579084 false 2021-05-01 2022-04-30 2022-04-30 The principal activity of the company is the provision of financial management services. Digita Accounts Production Advanced 6.30.9574.0 true 12579084 2021-05-01 2022-04-30 12579084 2022-04-30 12579084 bus:Director1 1 2022-04-30 12579084 bus:OrdinaryShareClass1 2022-04-30 12579084 bus:OrdinaryShareClass2 2022-04-30 12579084 bus:OrdinaryShareClass3 2022-04-30 12579084 bus:OrdinaryShareClass4 2022-04-30 12579084 core:CurrentFinancialInstruments 2022-04-30 12579084 core:CurrentFinancialInstruments core:WithinOneYear 2022-04-30 12579084 core:OfficeEquipment 2022-04-30 12579084 bus:SmallEntities 2021-05-01 2022-04-30 12579084 bus:AuditExemptWithAccountantsReport 2021-05-01 2022-04-30 12579084 bus:FullAccounts 2021-05-01 2022-04-30 12579084 bus:SmallCompaniesRegimeForAccounts 2021-05-01 2022-04-30 12579084 bus:RegisteredOffice 2021-05-01 2022-04-30 12579084 bus:Director1 2021-05-01 2022-04-30 12579084 bus:Director1 1 2021-05-01 2022-04-30 12579084 bus:OrdinaryShareClass1 2021-05-01 2022-04-30 12579084 bus:OrdinaryShareClass2 2021-05-01 2022-04-30 12579084 bus:OrdinaryShareClass3 2021-05-01 2022-04-30 12579084 bus:OrdinaryShareClass4 2021-05-01 2022-04-30 12579084 bus:PrivateLimitedCompanyLtd 2021-05-01 2022-04-30 12579084 bus:Agent1 2021-05-01 2022-04-30 12579084 core:OfficeEquipment 2021-05-01 2022-04-30 12579084 countries:EnglandWales 2021-05-01 2022-04-30 12579084 2021-04-30 12579084 bus:Director1 1 2021-04-30 12579084 core:OfficeEquipment 2021-04-30 12579084 2020-04-29 2021-04-30 12579084 2021-04-30 12579084 bus:Director1 1 2021-04-30 12579084 bus:OrdinaryShareClass1 2021-04-30 12579084 bus:OrdinaryShareClass2 2021-04-30 12579084 bus:OrdinaryShareClass3 2021-04-30 12579084 bus:OrdinaryShareClass4 2021-04-30 12579084 core:CurrentFinancialInstruments 2021-04-30 12579084 core:CurrentFinancialInstruments core:WithinOneYear 2021-04-30 12579084 core:OfficeEquipment 2021-04-30 12579084 bus:Director1 1 2020-04-29 2021-04-30 12579084 bus:OrdinaryShareClass4 2020-04-29 2021-04-30 12579084 bus:Director1 1 2020-04-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12579084

Wessex Medical Financial Services Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 April 2022

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Wessex Medical Financial Services Limited
for the Year Ended 30 April 2022

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Wessex Medical Financial Services Limited for the year ended 30 April 2022 as set out on pages 2 to 8 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Wessex Medical Financial Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Wessex Medical Financial Services Limited and state those matters that we have agreed to state to the Board of Directors of Wessex Medical Financial Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wessex Medical Financial Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Wessex Medical Financial Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Wessex Medical Financial Services Limited. You consider that Wessex Medical Financial Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Wessex Medical Financial Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

13 September 2022

 

Wessex Medical Financial Services Limited

(Registration number: 12579084)
Balance Sheet as at 30 April 2022

Note

2022
£

2021
£

Fixed assets

 

Tangible assets

4

165

248

Current assets

 

Debtors

5

19,621

21,129

Cash at bank and in hand

 

40,729

31,380

 

60,350

52,509

Creditors: Amounts falling due within one year

6

(33,531)

(36,044)

Net current assets

 

26,819

16,465

Total assets less current liabilities

 

26,984

16,713

Provisions for liabilities

(31)

(47)

Net assets

 

26,953

16,666

Capital and reserves

 

Called up share capital

7

130

120

Retained earnings

26,823

16,546

Shareholders' funds

 

26,953

16,666

For the financial year ending 30 April 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 30 July 2022 and signed on its behalf by:
 

 

Wessex Medical Financial Services Limited

(Registration number: 12579084)
Balance Sheet as at 30 April 2022

.........................................
Owen Beswick
Director

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2022

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2022

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

25% - Straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2022

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2021 - 2).

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 May 2021

331

331

At 30 April 2022

331

331

Depreciation

At 1 May 2021

83

83

Charge for the year

83

83

At 30 April 2022

166

166

Carrying amount

At 30 April 2022

165

165

At 30 April 2021

248

248

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2022

5

Debtors

Current

2022
£

2021
£

Trade debtors

19,499

20,972

Prepayments

122

157

 

19,621

21,129

6

Creditors

Note

30 April 2022
 £

30 April 2021
 £

Due within one year

 

Amounts due to related parties

8

5

7,245

Accrued expenses

 

1,500

1,500

Corporation tax liability

32,026

27,299

 

33,531

36,044

7

Share capital

Allotted, called up and fully paid shares

 

2022

2021

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

10

10

10

10

Ordinary B shares of £1 each

10

10

10

10

Ordinary C shares of £1 (2021 - £0) each

10

10

-

-

 

130

130

120

120

 

Wessex Medical Financial Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2022

8

Related party transactions

Transactions with directors

2022

At 1 May 2021
£

Advances to director
£

At 30 April 2022
£

Owen Beswick

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

(7,245)

7,238

(7)

       
     

 

2021

At 29 April 2020
£

Other payments made to company by director
£

At 30 April 2021
£

Owen Beswick

The directors loan account balance is undated, unsecured, interest free and repayable on demand.

-

(7,245)

(7,245)